Serum osteopontin and tissue inhibitor of metalloproteinase 1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma - Wikidata - wikimedia - TriplyDB

Serum osteopontin and tissue inhibitor of metalloproteinase 1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma

Serum osteopontin and tissue inhibitor of metalloproteinase 1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma

http://www.wikidata.org/entity/Q36622740

about

Systematic review of peri-operative prognostic biomarkers in pancreatic ductal adenocarcinoma SIBLINGs and SPARC families: their emerging roles in pancreatic cancer Biomarkers in pancreatic adenocarcinoma: current perspectives Serum IGFBP2 and MSLN as diagnostic and prognostic biomarkers for pancreatic cancer.Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study.Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies.RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma Plasma levels and diagnostic utility of VEGF, MMP-9, and TIMP-1 in the diagnosis of patients with breast cancer.Proteomic profiling of the tumor microenvironment: recent insights and the search for biomarkers.NF‑κB inhibition is associated with OPN/MMP‑9 downregulation in cutaneous melanoma.Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9.Role of osteopontin in the pathophysiology of cancer.The need for effective pancreatic cancer detection and management: a biomarker-based strategy.Current and future biomarkers for pancreatic adenocarcinoma.High Glucose Accelerates Cell Proliferation and Increases the Secretion and mRNA Expression of Osteopontin in Human Pancreatic Duct Epithelial Cells.Human osteopontin: Potential clinical applications in cancer (Review)Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma.Novel biomarkers and endoscopic techniques for diagnosing pancreaticobiliary malignancy Prospects for developing an accurate diagnostic biomarker panel for low prevalence cancers.Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer.Human aqueous humor levels of transforming growth factor-β2: Association with matrix metalloproteinases/tissue inhibitors of matrix metalloproteinases.Correlations Between MMPs and TIMPs Levels in Aqueous Humor from High Myopia and Cataract Patients.Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer.Pancreatic cancer: Current status and Challenges.Ten hub genes associated with progression and prognosis of pancreatic carcinoma identified by co-expression analysis.Runx3 and Cell Fate Decisions in Pancreas Cancer.Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis.Protein Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma: Progress and Challenges.The role of osteopontin in the progression of solid organ tumour.The hepatic pre-metastatic niche in pancreatic ductal adenocarcinoma.Serum level of co-expressed hub miRNAs as diagnostic and prognostic biomarkers for pancreatic ductal adenocarcinoma

P2860

Q26739910-8F8F3632-D291-4736-A3DE-2CA92640AB6D Q27027759-78FB4A62-FAB1-4FE1-9CBA-2DDE37F90AB4 Q28072309-C2352A83-0239-4CA9-89D7-6F36631B566C Q33929696-8E002A72-95A3-46DE-A8F6-9B0D196E9CFA Q35152701-9F670F2D-9926-4666-BEBF-F3EA56743061 Q35678051-8A0E6F88-6D86-471E-8371-BC2ACCF6A257 Q35690596-4578F617-542B-46F3-BB03-DCB9A709BB35 Q36631494-D2B5A5EC-008A-4AAA-A15E-4BF2F88F9E55 Q37689678-9752B47A-1573-4563-869E-66DF38008E18 Q37707767-7836992C-D482-4E78-A0B2-8D8CABDF3549 Q38129331-5163104D-7188-49E6-8BE2-82A0BB89D7C6 Q38198463-A3223730-DD33-40F5-B51E-3C88E77EB53F Q38591066-A664C859-9F25-4DEB-A410-FF10283C5001 Q38670577-53AF11FC-28E0-49CD-BDE5-2512B015D796 Q38707172-C614785F-9AEB-428B-AC9C-CE4E86826D07 Q39261041-E0F91004-8FF3-40A7-AE5D-79EA3FE62D54 Q40704991-F3B08793-9006-4846-B3EC-990C105994DA Q41624551-E74A3C1D-AAD3-44E4-9873-84F0A9905935 Q41779898-367B7FA9-E512-49FA-B553-22DD4BADE6A5 Q46289482-23443C9F-450C-42EA-B1BE-B32617CE2E9F Q47127174-BE1CCB8C-3336-4873-B064-9C7D762D05BA Q47889885-9AA85C2D-8AAC-45F9-9B46-04BE829C6C12 Q48113573-26A15EB9-0994-4BB9-86EC-E97586AFEF85 Q50195669-3D55D465-DB69-4852-AFC2-BD7798653790 Q50332191-BE1799DE-76BC-4A68-8D5A-359B887C2CB8 Q51097608-F39E9607-CB19-4556-9910-51F272AA4F9A Q51697993-D53900E3-B734-41BB-93D7-AB99E3CB4E40 Q52666355-C92D2243-F473-4448-A084-45C203C4EDEF Q52676361-7DC54B88-B30A-461E-9EC5-E8E3D81B4655 Q55443866-33AAF91F-65BF-4BFE-9BB2-099FA5AEC80E Q58573918-0F671CB3-2A04-4614-A435-DD2831CCE38D

P2860

Serum osteopontin and tissue inhibitor of metalloproteinase 1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma

http://www.wikidata.org/entity/Q36622740

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Serum osteopontin and tissue i ...... for pancreatic adenocarcinoma

@ast

Serum osteopontin and tissue i ...... for pancreatic adenocarcinoma

@en

type

label

Serum osteopontin and tissue i ...... for pancreatic adenocarcinoma

@ast

Serum osteopontin and tissue i ...... for pancreatic adenocarcinoma

@en

prefLabel

Serum osteopontin and tissue i ...... for pancreatic adenocarcinoma

@ast

Serum osteopontin and tissue i ...... for pancreatic adenocarcinoma

@en

P1433

Q36622740-14B9CECA-B1A0-46B7-8E30-F1E912EE7BD2

P1476

Q36622740-571C5ED2-6AE9-4275-B0B3-76B39D69C160

P2093

Q36622740-35FF3E78-CCF2-4CAC-B808-165A0F5BC518

Q36622740-4BCF0BB0-86FE-43BC-BAB2-08E50E26B143

Q36622740-624C8B69-EFC6-43DC-BF84-AE832F6C3E04

Q36622740-A1D556CD-B815-4464-8BB5-232DCCFD2596

Q36622740-A3BE9B52-DC10-4E94-BA84-96FEDD9D5793

Q36622740-B9DFEAF0-DA93-44F2-A1C7-755560042325

Q36622740-D69E25CC-2888-4003-8270-4414AD11C612

P2860

Q36622740-0B5423BC-1DE5-4B16-A943-8819BB5894F8

Q36622740-0FFE0A26-B097-45F9-A9CD-1AC83B9B87B8

Q36622740-1B3BB81F-2801-4D77-84A4-F0B90B1B126E

Q36622740-530BE6D9-1A1D-413F-A4C7-DAE94DA3CF85

Q36622740-85364FD8-E00C-4C2D-A23A-B2E502074005

Q36622740-9E56FC2C-EA49-4FD0-B818-AB6522C5C063

Q36622740-BE16DD97-D8B3-4C87-9CFA-DCD0210EAD30

Q36622740-CB50B80D-5FA1-452C-A6C7-E9217020DCCC

Q36622740-D015BEE8-76D2-46D5-8A9C-73675697A279

Q36622740-D3506CC4-BD26-431B-83F2-BB85704DAA46

P304

Q36622740-CF2C7D3F-5E2F-4236-9AF3-18635D915130

P31

Q36622740-FFCE9C92-3932-4E46-A7E5-D5BCFD7373E2

P356

Q36622740-7B7C7CF6-4E80-4499-890A-80AB4DCAB1AB

P433

Q36622740-F8E5AD13-966C-41D1-B9CE-6EFF2903A710

P478

Q36622740-F097E860-88B7-4654-93C9-25CCF304CF4D

P577

Q36622740-7C025B4A-B328-4D60-9447-6C64B76EA7D9

P698

Q36622740-1ACA2239-7385-43DB-A7E5-17D5CDEABC4D

P921

Q36622740-6EDA9E8F-4F72-408F-9E0A-F7C66A6FD7F6

Q36622740-A843AF09-0D74-4E3D-9F65-BE8170AE5020

P932

Q36622740-8D90708D-010D-4DF9-8770-F6107552BC44

P356

MPA.0B013E31825E354D

P1433

P1476

Serum osteopontin and tissue i ...... for pancreatic adenocarcinoma

@en

P2093

Courtney L Scaife

http://www.w3.org/2001/XMLSchema#string

Douglas G Adler

http://www.w3.org/2001/XMLSchema#string

Katherine E Poruk

http://www.w3.org/2001/XMLSchema#string

Kenneth M Boucher

http://www.w3.org/2001/XMLSchema#string

Lyska L Emerson

http://www.w3.org/2001/XMLSchema#string

Matthew A Firpo

http://www.w3.org/2001/XMLSchema#string

Sean J Mulvihill

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2010

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer

Serum biomarker panels for the detection of pancreatic cancer

A compendium of potential biomarkers of pancreatic cancer.

Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling.

TIMP-1 gene deficiency increases tumour cell sensitivity to chemotherapy-induced apoptosis.

Osteopontin: a potentially important therapeutic target in cancer.

TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro.

TIMP-1 overexpression in pancreatic cancer attenuates tumor growth, decreases implantation and metastasis, and inhibits angiogenesis.

P304

193-197

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MPA.0B013E31825E354D

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23407481

http://www.w3.org/2001/XMLSchema#string

P921

P932

3576824

http://www.w3.org/2001/XMLSchema#string